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Sympathetic Inhibition of Accommodation after
Sustained Nearwork in Subjects with Myopia
and Emmetropia
Balamurali Vasudevan,1 Kenneth J. Ciuffreda,1 and Bernard Gilmartin2
PURPOSE. The purposes of the present study were to assess the
effect of a sympathetic inhibitory pharmacologic agent, timolol
maleate, on the magnitude of nearwork-induced transient my-
opia (NITM) and its decay in different refractive groups for an
extended near task duration and to determine the proportion
of the young adult population manifesting effective sympa-
thetic access under naturalistic closed-loop viewing condi-
tions.
METHODS. Ten subjects with emmetropia and 10 with myopia
were tested. They read binocularly for 1 hour at a distance of
35 to 40 cm. NITM was calculated as the difference in distance
refractive state after task as compared with before task imme-
diately after reading. All subjects received timolol maleate to
block the sympathetic nervous system and betaxolol as a con-
trol agent in independent test sessions separated by at least 3
days. Forty minutes after drug instillation, the NITM measure-
ment procedure was repeated.
RESULTS. Initial NITM magnitude was larger in subjects with
myopia than in subjects with emmetropia before and after
timolol instillation. Furthermore, NITM magnitude in subjects
with sympathetic access was increased after timolol instilla-
tion. In contrast, with the control agent betaxolol, there was
no increase. NITM decay duration to baseline was increased
after timolol instillation in the subjects with myopia only. Only
15% of the subjects (n  3 subjects with myopia) demon-
strated effective and significant access to sympathetic facility.
CONCLUSIONS. Subjects with myopia demonstrated an increase
in decay duration with timolol, thus suggesting impaired sym-
pathetic inhibition of accommodation. This may be a precursor
for myopia progression in some persons. (Invest Ophthalmol
Vis Sci. 2009;50:114–120) DOI:10.1167/iovs.08-1762
Accommodation refers to the process whereby alterationsoccur in the dioptric power of the crystalline lens to
obtain and maintain a clear image of an object at the fovea
when focus is changed.1 It is produced by systematic variations
in the lenticular and extralenticular structures of the human
eye.1 The accommodative system receives dual pharmacologic
innervation from the sympathetic and parasympathetic divi-
sions of the autonomic nervous system.2
The sympathetic and parasympathetic systems have com-
plementary actions. Parasympathetic input is mediated by the
action of acetylcholine on muscarinic receptors, whose level of
excitatory stimulation results in rapid (1-second) changes in
the accommodative state.2,3 Although several types of musca-
rinic (cholinergic) receptors have been found (M1, M2, M3,
M4), the M3 receptor is primarily involved in ciliary muscle
contraction. In contrast, the sympathetic receptors in the cili-
ary smooth muscle are principally inhibitory 2 receptors and
possibly inhibitory  receptors.2,3 The sympathetic system is
inhibitory in nature and thus acts to produce a relative de-
crease in accommodation.4 Furthermore, the sympathetic sys-
tem is slow in onset (40 seconds) and smaller in effect than
the parasympathetic system.4,5
The ciliary muscle is one of the most important extralen-
ticular components of the eye involved in accommodation
because its force deforms the crystalline lens1 to produce clear
retinal imagery. It receives sympathetic stimulation primarily
from 2 adrenergic receptors.2 Approximately 90% of the
-receptors are of the type 2 variety.6 Gilmartin and Hogan7
found that with instillation of a  agonist, tonic accommoda-
tion decreased 0.50 D to produce a hyperopic shift, whereas
with instillation of a -blocker, it increased 1.00 D to produce
a myopic shift. -Blockers may also influence the closed-loop
far point of accommodation and open-loop accommodative
adaptation.8 Hence, to understand better the mechanism of
accommodation and its possible relation to myopia, use of a
pharmaceutical agent that blocks the sympathetic system gains
significance.
Two models have been proposed that attempt to link sym-
pathetic inhibition of accommodation and myopia progres-
sion.9 The first model assumes a deficit in sympathetic input
alone, in association with normal parasympathetic input. This
would result in enhanced accommodative aftereffects, such as
nearwork-induced transient myopia (NITM).9,10 In addition, it
would produce a relatively prolonged period of decay of any
induced myopic shift after nearwork. The second model as-
sumes a deficit in the sympathetic and parasympathetic inputs.
That is, because the level of sympathetic activation is positively
correlated with the level of parasympathetic activity, a de-
crease in the latter would lead to a decrease in the former, thus
producing a decrease in the accommodative response during
nearwork followed by an enhanced accommodative aftereffect
during subsequent far viewing.11 All of these effects are poten-
tially myopiagenic.9–11
Several studies have reported on sympathetic inhibition
related to decay of the accommodative response under open-
loop viewing conditions in the dark (for a review, see Chen et
al.9). These studies have primarily measured accommodative
adaptation after short durations of nearwork and then reas-
sessed the same after instillation of a pharmaceutical agent
such as timolol (a nonselective -antagonist) or betaxolol (a
1-selective antagonist). Whereas timolol produces a decrease
in intraocular pressure and an increase in tonic accommoda-
tion, a pharmacologic control agent such as betaxolol pro-
duces a decrease in intraocular pressure only12 and thus serves
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as a selective control agent. For example, Gilmartin and Bulli-
more13 measured accommodative adaptation for visual tasks at
0.3 D and 5 D in young adults with emmetropia. For the 5-D
task, they reported that the post-task accommodative response
decayed to baseline within 60 seconds, whereas with the
addition of topical instillation of timolol, the decay duration
increased to 80 seconds. However, this effect was not ob-
served at the lower accommodative stimulus level, which typ-
ically decayed in less than 50 seconds for both conditions.
Presumably this was because of the relatively low pharmaco-
logic drive from the parasympathetic system.2 Hence, when
sympathetic innervation was blocked and considerable accom-
modation was activated, decay duration was increased. Later,
Gilmartin and Bullimore14 measured accommodative adapta-
tion in subjects with late-onset myopia (LOM) and in subjects
with emmetropia after a 10-minute visual counting task at
distances equivalent to 1, 3, and 5 D. They reported that the
decay duration of accommodative adaptation after nearwork
was significantly increased in subjects with myopia as com-
pared to subjects with emmetropia at the higher accommoda-
tive levels only (3 and 5 D). Again, lack of effect was found for
the lowest stimulus level. From this and other findings, Gilmar-
tin and Winfield12 assumed that the role of sympathetic inner-
vation of the ciliary muscle may be, for example, to attenuate
the accommodative response induced by periods of intense
close work and thus reduce the risk of larger and prolonged
post-task transitory pseudomyopic changes. Based on the find-
ings of previous investigations,14,15 Gilmartin and Bullimore14
proposed that the onset of LOM (e.g., because of myopic
nearwork susceptibility11,16,17) might follow a progressive se-
quence: a sympathetic inhibitory deficit according to model
one described earlier, followed by a propensity to exhibit an
accommodative aftereffect after nearwork, and the resultant
retinal defocus/blur that would be cumulative because of this
adaptive process. This would result in increased vitreal cham-
ber depth and, hence, axial myopia. Later, Gilmartin and Win-
field12 measured the open-loop accommodative decay after a
3-minute near task with the pharmacologic addition of timolol
or betaxolol. They reported similarity in accommodative re-
sponse profiles to the -receptor antagonists in the subjects
with early-onset myopia (EOM), LOM, and emmetropia. Thus,
the deficit in sympathetic inhibition appeared to be indepen-
dent of refractive state.
There is a clear association between sustained near vision
and the development of myopia (for reviews, see Rosenfield
and Gilmartin18). Thus, sympathetic inhibition may have an
important etiological role in the development of certain classes
of myopia in predisposed persons.5,8,15 However, open-loop
accommodative responses are not representative of real-life
situations in which blur-related visual feedback is present.
Hence, knowledge of the analogous closed-loop accommoda-
tive response properties (NITM) gains importance.11
The closed-loop distance accommodative response after
sustained nearwork, namely NITM, has been assessed before
and after blockade of the sympathetic system in earlier studies.
For example, Winn et al.19 reported that when timolol was
used in emmetropic subjects, both the gain of the dynamic
accommodative response for a target of low temporal fre-
quency (0.3 Hz or less) and the near-to-far closed-loop step-
wise accommodative response increased. Thus, an increase in
NITM decay time may be predicted under these conditions.
Later, Mallen et al.20 measured open- and closed-loop post-task
accommodative responses in subjects with emmetropia and
subjects with myopia (LOM and EOM) after a near task of either
10 seconds or 3 minutes. In subjects with effective access to
sympathetic facility, instillation of timolol resulted in an in-
crease in the accommodative decay to baseline for the
3-minute task. However, no difference was observed for the
10-second task because this duration was too short for any
substantial drug effect to occur given the slow temporal char-
acteristics of sympathetic inhibition. In contrast, betaxolol pro-
duced no difference in time constant for either the 10-second
or 3-minute task period. The Mallen et al.20 results suggested
that sympathetic inhibitory facility was effective in only a
proportion of the subjects (27% of the subjects with em-
metropia, 21% of the subjects with EOM, and 29% of the
subjects with LOM). Not all subjects exhibited this feature, and
the frequency distribution was relatively similar in each group.
Thus, it appears that a significant proportion of the population
may have a reduced propensity to myopia attributable to the
presence of a sympathetic inhibitory facility that is indepen-
dent of refractive status. However, these findings were never
confirmed for longer durations of nearwork (e.g., 1 hour) in
young adults.
The aims of the present investigation were threefold: first,
to assess the magnitude of NITM after a 1-hour near task, with
and without blockade of the sympathetic system; second, to
ascertain refractive error dependency of the sympathetic in-
hibitory function; and third, to determine the percentage of the
population with effective and significant access to the latter.
METHODS
Subjects
Twenty optometry and graduate students (10 subjects with em-
metropia and 10 subjects with myopia) were recruited from the SUNY
State College of Optometry. They ranged in age from 21 to 35 years
(mean age, 24). There were 9 men and 11 women. All had normal
vision function. They constituted a subgroup of subjects from an
earlier related study in our laboratory.10 The noncycloplegic refractive
status of each subject was obtained with an objective, open-field,
infrared autorefractor (R-1; Canon, Lake Success, NY). This information
was used to classify the subjects as those with myopia or those with
emmetropia. It was also confirmed subjectively. Subjects with myopia
had a spherical equivalent refraction that ranged from 0.5 to 6 D,
with a mean of 2.12 D. Subjects with emmetropia had a spherical
equivalent refraction that ranged from0.5 D to0.25 D, with a mean
of 0.15 D. The cylindrical component was  1.00 D, with a mean
of 0.64 D. All subjects with myopia were corrected with their
habitual soft contact lenses, which resulted in a distance visual acuity
of 20/20 or better monocularly and binocularly at distance and near.
Subjects with a history of respiratory disorders, glaucoma, or narrow
anterior chamber angles were excluded from the study. Informed
consent was obtained from each subject after the nature and possible
consequences of the study were explained. The research followed the
tenets of the Declaration of Helsinki and was approved by the college’s
internal review board.
Instrumentation
All measurements of refractive state were obtained objectively (R-1;
Canon), which is a widely used, binocular, open-field, infrared autore-
fractor for vision research.5 This instrument provides rapid measure-
ments (approximately every 2 seconds) of refractive state. The power
range is 15 DS and 7 DC, the dioptric resolution is 0.12 D, and the
cylindrical axis resolution is 1° (for a detailed explanation, see McBrien
and Millodot21).
Procedures
Figure 1 shows a schematic representation of the methodology.
Closed-loop accommodative response measurements are described
below.
Pre-task. All subjects were seated in total darkness for 5 minutes
to allow for the dissipation of any transient accommodative effects.22
The distance refractive state was measured in the right eye, while the
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subject binocularly viewed 20/30 Snellen letters at 6 m. During all test
periods, contact lenses were worn by the subjects with myopia to
correct their distance refractive state and to avoid the potential of
spectacle reflections that might interfere with the measurements.23
Twenty measurements of the distance refractive state were obtained
with the autorefractor (R-1; Canon) with the subjects gazing at the
distant target, and the spherical equivalent was calculated to the
corneal plane.
Task. Subjects were seated at a desk in the laboratory under
fluorescent room illumination and read optometric lecture notes at a
distance of 35 to 40 cm during the 1-hour test period. They were
instructed to maintain the text in focus at all times, and the distance of
the reading material was assessed every 15 minutes by the examiner.
Post-task. Immediately after the 1-hour period of reading, sub-
jects were quickly (2 seconds) seated in the autorefractor and asked
to focus on the distant Snellen target, and the distance refractive state
was assessed every 2 seconds for a period of 120 seconds. Subjects
were questioned about target clarity periodically to ensure that they
were focusing accurately.
Pharmaceutical Agents
Two pharmaceutical agents, timolol maleate (0.5%; Alcon, Fort Worth,
TX) and betaxolol HCl (0.5%; Alcon), were used to block the sympa-
thetic adrenoceptors without change in pupil diameter.2 Timolol acts
on the ciliary smooth muscle to modulate autonomic control of the
accommodative response and to decrease intraocular pressure (IOP).12
In contrast, betaxolol was used as a pharmaceutical control; it only
produces a decrease in IOP and thus differentiates the interaction
between the changes in IOP and accommodation. Before instillation of
these drugs, one drop of 0.5% proparacaine HCl was administered in
the each eye to inhibit reflex tearing on the subsequent instillation of
the  antagonist drug.
After completion of the closed-loop accommodative measure-
ments, the contact lenses were removed, and the IOP was measured in
each eye with a noncontact pneumatic tonometer (T1; Canon, Tokyo,
Japan). Then one drop of timolol (0.5%) was instilled in each eye.
Subjects were instructed to reinsert their contact lenses 10 minutes
after instillation of the timolol and to gaze on the distant target at all
times. Forty minutes after the timolol was instilled, IOP was measured
again, and the entire process was repeated immediately after comple-
tion of the 1 hour of nearwork.
Control Study
All subjects served as their own controls. They were randomly allo-
cated either timolol or betaxolol at an interval of at least 3 days. The
same test paradigm described earlier was used to measure the closed-
loop accommodative response before and after betaxolol instillation.
To achieve an ocular hypotensive effect approximately equivalent to
that of timolol,12 two drops of betaxolol (0.5%) were administered 5
minutes apart in each eye. IOP was measured before and after the task.
When compared with the timolol findings, these results reveal the
effect of the sympathetic inhibitory system on the accommodative
response characteristics under closed-loop viewing conditions.
Data Analysis
The data for each subject were divided into 10-second bin intervals.
Each bin contained five data points that were averaged within and
across subjects within each refractive group.11 Initial NITM was calcu-
lated from the five readings within the first 10-second bin. The post-
task minus pre-task difference in distance refractive state represented
the NITM dioptric magnitude. The time taken for the NITM magnitude
to dissipate in each subject, i.e., the time to decay to the pre-task
distance baseline level, was calculated for each subject, and then it was
averaged within each refractive group to obtain the mean decay dura-
tion. Regression analysis was conducted to determine mathematically
the decay duration. These calculations of the initial NITM magnitude
and its decay were obtained with and without use of the pharmaceu-
tical agents.
The difference in initial NITM magnitude and decay duration ob-
tained before and after timolol administration was calculated. Subjects
with a positive difference in initial NITM magnitude, and above the
noise level of the Canon autorefractor (0.06 D11), were identified and
classified as having access to sympathetic inhibition during the near
task. These subjects also exhibited longer (minimum 10 seconds)
decay duration after timolol instillation. Subjects with either no differ-
ence or a negative difference were classified as not having sympathetic
access.
RESULTS
Initial NITM Magnitude
Refractive Error. The initial NITM magnitude was assessed
immediately after 1 hour of nearwork before and after the
instillation of timolol (Fig. 2). Group means were the same
(0.22 D) before and after the instillation of timolol, as shown in
Figure 2. The myopic subgroup manifested means of 0.28 D
and 0.27 D, respectively; the emmetropic subgroup manifested
means of 0.14 D and 0.16 D, respectively. Two-way, repeated-
measures ANOVA for the factors of refractive error and drug
effect was performed with respect to the initial NITM magni-
tude. It revealed a significant effect for refractive group (F(1,32)
 12.39; P  0.001) but not for drug effect (F(1,32)  0.004;
P  0.94). Interaction effects were not significant (P  0.05).
A post hoc Fisher LSD test revealed that the initial NITM was
larger in subjects with myopia than in subjects with em-
metropia both before (P  0.01) and after (P  0.03) timolol
instillation.
Sympathetic Access. Subjects were assessed with respect
to their ability to demonstrate effective sympathetic access
FIGURE 1. Flow chart of the experi-
mental methodology. CL, contact lens.
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based on our specified criterion (Fig. 3). In subjects with
access to sympathetic facility, the initial NITM means before
and after timolol instillation were 0.15 D and 0.28 D, respec-
tively. In subjects without sympathetic access, the NITM
means before and after timolol instillation were 0.25 D and
0.19 D, respectively. Two-way, repeated-measures ANOVA for
the factors of sympathetic access and drug effect was per-
formed. No effect was observed with respect to sympathetic
access (F(1,32) 0.001; P 0.96) or drug effect (F(1,32) 0.78;
P  0.38). Interaction effects were significant (P  0.03). A
post hoc Fisher-LSD test revealed a significant effect (P 0.05)
for increased initial NITM magnitude in subjects with effective
sympathetic access after timolol application. Other relevant
comparisons were not significant.
Of the seven subjects exhibiting results suggesting effective
sympathetic access, four were emmetropic and three were
myopic. Initial NITM means before and after timolol instillation
were 0.22 D and 0.39 D in subjects with myopia and 0.08 D
and 0.15 D in subjects with emmetropia, respectively. Paired
t-tests were performed to compare the initial NITM magnitude
within each of these refractive groups. Only the subjects with
myopia exhibited a significant increase in NITM with timolol
(t(2)  22.51; P  0.01); the subjects with emmetropia did
not (t(3)  2.54; P  0.08).
Control. Initial NITM magnitude was assessed after 1 hour
of nearwork before and after instillation of betaxolol (Fig. 4).
The group means NITM were 0.17 D and 0.26 D, respectively.
The myopic subgroup manifested NITM magnitude means of
0.17 D and 0.27 D, respectively; the emmetropic subgroup
exhibited NITM magnitude means of 0.19 D and 0.23 D, re-
spectively. Two-way, repeated-measures ANOVA for the fac-
tors of refractive error and drug effect was performed. It was
not significant for either drug effect (F(1,16)  1.73; P  0.20)
or refractive group (F(1,16)  0.03; P  0.85). Interaction
effects were not significant (P  0.05).
Decay of NITM
Refractive Error. NITM decay was assessed as the time to
reach the zero pre-task baseline (Fig. 5). Group means decay to
baseline before and after timolol instillation were 50.7 seconds
and 66.8 seconds, respectively. In the subjects with em-
metropia, the decay to baseline means before and after timolol
instillation were 47.2 and 49.4 seconds, respectively. In the
subjects with myopia, the decay to baseline means before and
after timolol instillation were 54 and 82.5 seconds, respec-
tively. Two-way, repeated measures ANOVA for the factors of
drug effect (timolol) and refractive group was performed. It
revealed significance for the drug effect (F(1,44)  4.02; P 
0.05) but not for the refractive group (F(1,44) 2.39; P 0.13).
Interaction effects were not significant (P  0.05). A post hoc
Fisher-LSD test revealed that decay duration after the instilla-
tion of timolol was increased in the subjects with myopia
compared to the subjects with emmetropia (P  0.02). The
mean decay duration for the subjects with myopia was in-
creased after timolol instillation as compared with their prein-
stillation value (P  0.04).
FIGURE 2. Mean initial NITM plotted as a function of group and
refractive subgroup after 1 hour of nearwork before and after instilla-
tion of timolol. Plotted is the mean 1 SEM. G, group; M, subjects with
myopia; E, subjects with emmetropia.
FIGURE 3. Mean initial NITM plotted after 1 hour of nearwork before
and after instillation of timolol. Plotted is the mean  1 SEM. sym,
sympathetic access; non-sym, without sympathetic access.
FIGURE 4. Mean initial NITM plotted as a function of group and
refractive subgroup after 1 hour of nearwork before and after instilla-
tion of betaxolol. Plotted is the mean  1 SEM.
IOVS, January 2009, Vol. 50, No. 1 Sympathetic Inhibition after Sustained Nearwork 117
Downloaded From: https://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/932956/ on 10/08/2018
Sympathetic Access. Subjects were tested with respect to
their ability to demonstrate effective sympathetic access (Fig.
6). In subjects with apparent sympathetic access (n  7), the
decay to baseline before and after timolol instillation group
means were 29.2 seconds and 69.2 seconds, respectively. In
subjects without apparent sympathetic access, the decay to
baseline before and after timolol instillation group means were
56.8 seconds and 65.9 seconds, respectively. Two-way, repeat-
ed-measures ANOVA for the factors of drug effect and sympa-
thetic access was performed. It revealed a significant effect for
drug action (F(1,44)  5.47; P  0.02) but not for sympathetic
access (F(1,44)  1.32; P  0.25). Interaction effects were not
significant (P  0.05). A post hoc Fisher-LSD test revealed that
in subjects with apparent sympathetic access, decay duration
after the instillation of timolol was significantly increased (P 
0.02). No other relevant comparisons were significant.
Of the seven subjects exhibiting results suggesting effective
sympathetic access, four were emmetropic and three were
myopic. Decay durations to baseline before and after timolol
instillation means were 42 seconds and 108 seconds in subjects
with myopia and 20 and 43 seconds in subjects with em-
metropia, respectively. Paired t-tests were performed to com-
pare the NITM decay duration within each of these refractive
groups. Only the subjects with myopia demonstrated a signif-
icant increase in decay duration with timolol (t(2)  4.88;
P 0.03); the subjects with emmetropia did not (t(3)2.18;
P  0.11).
Control. Decay duration was assessed in the emmetropic
and myopic subgroups (Fig. 7). The decay to baseline before
and after betaxolol instillation group means were 52.3 and 72.3
seconds, respectively. In the subjects with emmetropia, the
decay to baseline before and after betaxolol instillation group
means were 60 and 67.5 seconds, respectively. In the subjects
with myopia, the decay to baseline before and after timolol
instillation group means were 56.8 and 75 seconds, respec-
tively. Two-way, repeated-measures ANOVA for the factors of
drug effect (betaxolol) and refractive group revealed neither a
drug (F(1,44)  0.70; P  0.40) nor a refractive group (F(1,44) 
0.02, P  0.88) effect. Interaction effects were not significant
(P  0.05).
DISCUSSION
There are two important and new findings in the present study,
as assessed under closed-loop viewing conditions. First, with
addition of the sympathetic inhibitor timolol, there was a
significant increase in NITM decay duration after the sustained
1-hour near task. Furthermore, refractive error susceptibility
was found—that is, decay duration was significantly longer in
the subjects with myopia. Second, 35% (n  7) of the subjects
demonstrated apparent effective access to sympathetic inhibi-
tion under the specific experimental conditions based on the
conventional criterion of inherent NITM and decay duration.
However, only subjects with myopia (n  3) exhibited a
significant effect, representing 15% of the total sample size.
This is the first study to report on NITM closed-loop accom-
modative responsivity with and without the pharmacologic
addition of timolol. After timolol instillation, the initial NITM
magnitude was found to be similar across refractive groups,
whereas the decay duration revealed refractive error suscepti-
bility. In other words, the subjects with emmetropia demon-
strated a relatively rapid decay back to baseline, whereas the
subjects with myopia exhibited a prolonged post-task decay
duration. These findings may provide insight into and bear
relation to nearwork-induced permanent myopia.10 After short
durations of nearwork, a small (0.3 D) and transient myopic
shift is typically induced in subjects with myopia.15 This myo-
pic shift decays to baseline (in 30 seconds or longer) when one
FIGURE 5. Decay of NITM as a function of refractive subgroup after 1
hour of nearwork before and after instillation of timolol. Plotted is the
mean.
FIGURE 6. Decay of NITM in subjects (top) with sympathetic access
and (bottom) without sympathetic access after 1 hour of nearwork
before and after instillation of timolol. Plotted is the mean.
FIGURE 7. Decay of NITM as a function of refractive subgroup after 1
hour of nearwork before and after instillation of betaxolol. Plotted is
the mean.
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performs a low dioptric demand task such as focusing on a
distant target, but decay characteristics varied among the re-
fractive groups; they were found to be prolonged in the sub-
jects with myopia.11,16,17 Such prolonged decay is consistent
with a recently advanced theory of myopia development.24
When closely spaced cycles of near-far-near work take place,
such as within 30 seconds or less, decay of the NITM may not
be complete in some persons.11,25 By effectively functioning as
a low-powered plus lens, this residual NITM acts to reduce the
accommodative stimulus, and in turn the accommodative er-
ror,26 during the subsequent near viewing task, thus promoting
emmetropization through axial elongation (for a detailed ex-
planation, see Hung and Ciuffreda24).
The present findings demonstrated that decay duration in
the myopic group was increased after timolol instillation, thus
raising an important possible link to myopia development. The
sympathetic system may serve in a protective capacity by
slightly reducing the accommodative response produced by
the parasympathetic innervation during a sustained near activ-
ity such as reading.7,15 In the present experiment, when timo-
lol was administered, sympathetic innervation was blocked
and, thus, its protective function was eliminated. This resulted
in increased decay with a potential for myopiagenesis,9–12,20 as
described earlier.
Previous studies have reported that the accommodative
response under open-loop viewing conditions (i.e., in the dark
without visual feedback) was modified with the addition of a
sympathetic inhibitor, such as timolol.12,20 However, they
found lack of refractive error dependency. Since the present
study was performed using a more naturalistic closed-loop
viewing and testing paradigm, and hence included the pres-
ence of blur-related visual feedback, it is not surprising that the
present results differed from those of previous investigations.
In the former, blur feedback had the potential to interact with
the pharmacologic effect; in the latter, it did not. This is
consistent with the notion that blur processing may be less
effective in subjects with myopia.27 In addition, these previous
studies used short near-task durations (e.g., 3 minutes), but the
present investigation incorporated a much longer reading du-
ration (60 minutes).
The present results suggest that subjects exhibiting in-
creased initial NITM with the instillation of timolol have effec-
tive access to sympathetic inhibitory facility. A recent study has
also provided evidence of such sympathetic inhibitory facility
in 27% of subjects with emmetropia, 21% of subjects with
early-onset myopia, and 29% of subjects with late-onset myopia
(i.e., approximately 25% of subjects with myopia), and in 26%
of the total group.20 Their results are in accord with a previ-
ously proposed model related to the role of sympathetic inhi-
bition of accommodation in myopia onset and its progression,
which suggested that the sympathetic branch of the autonomic
nervous system had reduced function in some subjects.20 A
similar finding was observed in the present study, although it
was performed under closed-loop viewing conditions. Based
on the initial criteria of the present experiment (see Subjects
and Methods), the findings revealed that only 7 of 20 (33%)
subjects demonstrated access to sympathetic inhibition medi-
ated by 2-adrenoreceptors. These seven subjects exhibited
increased initial NITM and a longer decay duration after the
1-hour near task and the subsequent post-task instillation of
timolol, whereas the subjects who did not exhibit evidence of
a sympathetic inhibitory effect (n  13) did not manifest a
significant change in these accommodative response charac-
teristics with timolol. Although all seven subjects (four subjects
with emmetropia, three subjects with myopia) demonstrated
increased initial NITM and decay duration based on our criteria
of any degree of difference, the subjects with myopia demon-
strated the largest difference (i.e., between pre- and post-
timolol); only that was statistically significant. In contrast, the
four subjects with emmetropia did not show a statistically
significant difference because the increased NITM and decay
duration in them were minimal. Thus, refractive error suscep-
tibility was again suggested. In reality, only 3 of 20 (15%)
subjects exhibited statistically significant sustained and effec-
tive sympathetic inhibitory function, which, when pharmaco-
logically blocked, resulted in significantly increased NITM de-
cay duration.
Similar findings of increased NITM decay duration, espe-
cially in subjects with myopia, have been reported in several
studies that did not involve pharmacologic intervention.11,17,25
For example, a recent study on young adults has reported that
up to 46% of the subjects with myopia demonstrated nonde-
cayed residual NITM over a post-task period of 2 minutes.11
Similar findings have been reported in children (Ciuffreda and
Thunyalukul. IOVS 1999;40:ARVO E-Abstract 2365; Wolffsohn
et al.28). As described earlier, a proportion of the population
that has access to sympathetic inhibitory facility may benefit
from its protective function (i.e., it decreases the decay time
subsequent to a near task.15 Thus, a major finding of the
present study—prevalence of substantial sympathetic function
in only 15% of the population—may be considered one of
several factors that determine whether a child becomes myo-
pic or remains emmetropic during the early developmental
years. This is an important finding that should be tested in
young children under naturalistic closed-loop viewing condi-
tions.
What may be the local pharmacologic basis for the nonre-
sponders? It is hypothesized that in nonresponders, the expres-
sion of autonomic adrenoreceptor function is attenuated, pos-
sibly by differential distribution and density of receptors,6
though the pharmacologic/physiologic nature of this attenua-
tion is obscure. When the protective action of the sympathetic
function is decreased, such persons may be more susceptible
to myopia, as mentioned. It could be hypothesized that to
control myopia progression, a selective 2-agonist (e.g., salbu-
tamol) might be considered. Interestingly, a recent investiga-
tion29 has examined sympathetic stimulation on accommoda-
tion using salbutamol. Chen29 reported that this drug
attenuated the initial magnitude and decay duration of accom-
modative adaptation in subjects with progressing myopia. Our
results obtained under closed-loop viewing conditions are con-
sistent with the findings of this investigation performed under
an open-loop testing paradigm. Thus, the use of salbutamol to
control myopia progression should be investigated under
closed-loop viewing conditions.
In the present study, timolol modified the accommodative
response and produced a decrease in IOP. Measurement of IOP
was performed at regular intervals throughout all phases of the
test protocol. IOP decreased by an average of 3 mm Hg before
the near task, and it remained the same after the sustained near
task. This reduction in IOP before and after nearwork provides
evidence for blocked sympathetic inhibitory function. In con-
trast, betaxolol produced an average 2.5-mm decrease in IOP
only, with no significant change in accommodative response,
as expected in its control capacity. This is consistent with the
first model involving decreased sympathetic facility alone as an
underlying mechanism.12
The post-task regression of NITM has been attributed to a
physiologic rebound effect.30 However, there may be an opti-
cal explanation related to the conventional hyperfocal distance
refraction.31 In this case, the far point of the eye is not made
conjugate to infinity; rather, the distal edge of the depth-of-field
establishes conjugacy. Because the depth of field dioptrically
measures at least 0.25 D,31 the far point can be extended
distally by 0.25 D or a little more, until true conjugacy with
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infinity is established. The far point may transiently extend to
infinity on its dynamic, physiologically based route to reestab-
lishment of the steady state.
The present findings suggest directions for future investiga-
tions. First, a longitudinal study involving sympathetic inhibi-
tory function and its effect on myopic growth in children
during their rapid ocular growth phase (6–12 years32) is criti-
cal. Second, because the prevalence of effective sympathetic
inhibitory function was found in a relatively small subset of
subjects, future studies should be performed in a larger group
of young adults to confirm and extend the finding. Third,
investigation of sympathetic inhibitory function in young sub-
jects with progressing myopia could be useful in better under-
standing the progression of myopia.
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